Cargando...

Objective evaluation of the role of vincristine in induction and maintenance therapy for myelomatosis. Medical Research Council Working Party on Leukaemia in Adults.

In the Medical Research Council's IVth trial in Myelomatosis the possible benefit of adding vincristine to first line treatment with intermittent melphalan and prednisone has been assessed. This was analysed in 530 patients who were randomly allocated to receive vincristine or not. Survival was...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: MacLennan, I. C., Cusick, J.
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 1985
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1977102/
https://ncbi.nlm.nih.gov/pubmed/3896288
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!